Compare GVH & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GVH | TNON |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.8M |
| IPO Year | 2023 | 2021 |
| Metric | GVH | TNON |
|---|---|---|
| Price | $1.05 | $3.37 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $44.38 |
| AVG Volume (30 Days) | 345.3K | ★ 9.3M |
| Earning Date | 07-14-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.90 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,944,000.00 |
| Revenue This Year | $1.85 | $46.86 |
| Revenue Next Year | N/A | $63.99 |
| P/E Ratio | $0.74 | ★ N/A |
| Revenue Growth | N/A | ★ 20.35 |
| 52 Week Low | $0.87 | $0.13 |
| 52 Week High | $6.46 | $17.84 |
| Indicator | GVH | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 43.54 |
| Support Level | $0.87 | $2.54 |
| Resistance Level | $1.13 | $4.18 |
| Average True Range (ATR) | 0.07 | 0.24 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 16.43 | 48.34 |
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.